Marc Beer is the CEO and co-founder of Renovia Inc. For over 25 years he has been at the helm of organizations in the biotechnology, devices and diagnostics spheres. His considerable prior experience in this regard has proved to be a boon for the two-year-old company. Learn more: https://www.slideshare.net/MarcBeer
Mr. Beer started Renovia with a lofty goal: to improve the process of diagnosis and the treatment of women suffering from pelvic floor disorders. Among the various related disorders of this type, urinary incontinence is one of the more bothersome and prevalent. Approximately 250 million women are affected by this condition globally.
Renovia has already produced a device which targets and adjusts the movement of the levator plate of women with urinary incontinence. Studies have shown that there is a distinction in the angle of this anatomical feature between women with pelvic disorders and those with normal support. The device’s sensors hone in on the patient’s movements and monitor them during physical therapy sessions as the muscle is being trained. This ensures that the progress made with each course of treatment, or lack thereof as the case may be, is accurately tracked.
The ultimate goal is to take the sensor technologies that are proprietary to Renovia and couple them with patient-specific health information obtained in real time from digital records in order to enhance the evaluation of different treatments. This stands not only to benefit individual patients but all chronic sufferers of pelvic floor disorders as a whole. Long-term, this information will be culled and lead to efficiencies in the delivery of care that were impossible before, thereby driving down overall costs.
Renovia’s leaders are excited at the prospect of creating more innovative devices with similar life-changing potential. To that end, they have secured $42.3 million in financing from various sources which include Series B equity and venture capital. These funds will be used to further develop the corporation, develop and advertise other products and to test these in clinical trials. Renovia also counts three integrated health networks as partners in these efforts. Mr. Beer has assured that the trajectory of this organization, dedicated to women’s health, is an exciting one.